PPSC, Author at Pivot Park Screening Centre

High-Throughput Hit Discovery for Ion Channels and G Protein-Coupled Receptors

New approaches for hit discovery against Ion Channels and GPCRs using the Fluorescent Imaging Plate Reader (FLIPR) technology. Ion channels

Cost Effective Screening in 384 and 1536 well plates

Discover the advantages of utilizing both 384 and 1536 well plates in high-throughput screening (HTS). Learn how enhanced flexibility, cost-effectiveness, and adaptability can optimize your research efforts. Partner with us for streamlined data management and a competitive edge in drug discovery.

Ultra-high throughput-based screening for the discovery of antiplatelet drugs affecting receptor dependent calcium signaling dynamics

Delia I. Fernández, Sara Troitiño, Vladimír Sobota, Bibian M. E. Tullemans, Jinmi Zou, Helma van den Hurk, Ángel García, Saman Honarnejad, Marijke J. E. Kuijpers & Johan W. M.

19th Annual Drug Discovery Chemistry

A dynamic conference for medicinal and biophysical chemists working in pharma, biotech, and academia. Focused on discovery and optimization challenges of small molecule drug candidates

Affinity Selection Mass Spectrometry whitepaper update

Update: Target engagement assessment of drug-like and pan-assay interfering compounds using Affinity Selection Mass Spectrometry

Pivot Park Screening Centre (PPSC) has adopted Affinity Selection Mass Spectrometry (ASMS) workflow into its daily high-throughput screening (HTS) operations.

ACE Drug Discovery Summit

A platform for scientists, researchers and decision makers from all over the world to debate on the latest scientific advances, trends, current challenges and futuristic advancements in Drug Discovery.